PCRX
Pacira BioSciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$26.35
−0.94%Forward multiples
Based on analyst estimates
- P/E forward
- 8.61x
- P/E 2026E
- 9.19x
- P/E 2027E
- 7.68x
- P/E 2028E
- 5.60x
- P/S forward
- 1.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 74.84x
- PEG TTM
- 0.10x
- Price / book
- 1.56x
- Price / sales
- 1.41x
- Price / cash flow
- 5.60x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 1.62x
- EV / EBITDA
- 10.56x
- EV / EBIT
- 65.68x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026